AstraZeneca
AZN
#58
Rank
โ‚ฌ241.50 B
Marketcap
155,72ย โ‚ฌ
Share price
2.88%
Change (1 day)
10.39%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: โ‚ฌ241.50 Billion

As of October 2026 AstraZeneca has a market cap of โ‚ฌ241.50 Billion. This makes AstraZeneca the world's 58th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ241.50 B-1.45%
2025โ‚ฌ245.05 B25.25%
2024โ‚ฌ195.66 B3.4%
2023โ‚ฌ189.22 B-3.52%
2022โ‚ฌ196.13 B22.4%
2021โ‚ฌ160.23 B50.46%
2020โ‚ฌ106.49 B-8.84%
2019โ‚ฌ116.82 B41.54%
2018โ‚ฌ82.53 B13.67%
2017โ‚ฌ72.61 B10.75%
2016โ‚ฌ65.56 B-17.08%
2015โ‚ฌ79.07 B7.38%
2014โ‚ฌ73.64 B37.24%
2013โ‚ฌ53.65 B21.08%
2012โ‚ฌ44.31 B-4.92%
2011โ‚ฌ46.60 B-4.74%
2010โ‚ฌ48.92 B2.93%
2009โ‚ฌ47.53 B11.9%
2008โ‚ฌ42.48 B-0.58%
2007โ‚ฌ42.72 B-31.27%
2006โ‚ฌ62.17 B-5.64%
2005โ‚ฌ65.88 B49.4%
2004โ‚ฌ44.10 B-32.21%
2003โ‚ฌ65.05 B12.77%
2002โ‚ฌ57.69 B-37.35%
2001โ‚ฌ92.09 B-4.61%
2000โ‚ฌ96.54 B31.02%
1999โ‚ฌ73.68 B105.13%
1998โ‚ฌ35.92 B24.76%
1997โ‚ฌ28.79 B28.82%
1996โ‚ฌ22.35 B

End of Day market cap according to different sources

On Oct 29th, 2026 the market cap of AstraZeneca was reported to be:

โ‚ฌ241.61 Billion
by Nasdaq info icon info icon
โ‚ฌ241.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ591.53 B 144.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ271.67 B 12.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ152.42 B-36.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ162.63 B-32.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ1.093 T 352.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ92.27 B-61.79%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ32.95 B-86.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ322.35 B 33.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ111.97 B-53.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ87.08 B-63.94%๐Ÿ‡ฌ๐Ÿ‡ง UK